6 Meridian’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$5.48M Sell
19,840
-612
-3% -$155K 0.4% 43
2021
Q3
$4.72M Sell
20,452
-2,879
-12% -$711K 0.37% 51
2021
Q2
$5.36M Sell
23,331
-731
-3% -$147K 0.42% 43
2021
Q1
$4.5M Sell
24,062
-11,411
-32% -$2.23M 0.38% 42
2020
Q4
$5.99M Sell
35,473
-372
-1% -$55.5K 0.57% 27
2020
Q3
$5.31M Buy
35,845
+20,936
+140% +$3.24M 0.55% 26
2020
Q2
$2.45M Sell
14,909
-36,365
-71% -$5.58M 0.26% 72
2020
Q1
$7.11M Sell
51,274
-103,548
-67% -$14.2M 0.75% 40
2019
Q4
$20.3M Buy
154,822
+76,219
+97% +$8.83M 1.78% 8
2019
Q3
$8.79M Buy
78,603
+24,823
+46% +$2.76M 0.86% 26
2019
Q2
$5.96M Buy
53,780
+22
+0% +$2.59K 0.6% 59
2019
Q1
$6.98M Buy
+53,758
New +$6.54M 0.7% 52
2018
Q3
Sell
-5,859
Closed -$500K 478
2018
Q2
$500K Sell
5,859
-100
-2% -$8.21K 0.05% 244
2018
Q1
$461K Sell
5,959
-64,356
-92% -$5.18M 0.05% 297
2017
Q4
$5.94M Buy
+70,315
New +$5.98M 0.69% 51

Other funds holding LLY

6 Meridian's LLY Position: Q4 2021 in Review

6 Meridian reduced its Eli Lilly (LLY) stake by 3% in Q4 2021, selling an estimated $155K and leaving 19,840 shares worth $5.48M. The position accounts for 0.4% of the portfolio, ranked #43.

6 Meridian first reported a position in LLY in Q4 2017 and has held it in 15 quarters since. The position peaked at $20.3M in Q4 2019. 2,304 funds tracked by Wall St. Rank hold LLY as of Q4 2021.

  • 6 Meridian held 19,840 shares of Eli Lilly worth $5.48M as of Q4 2021.
  • 6 Meridian sold 612 Eli Lilly shares in Q4 2021, an estimated $155K.
  • Eli Lilly made up 0.4% of 6 Meridian's portfolio in Q4 2021, its #43 holding.
  • 6 Meridian first reported a position in Eli Lilly in Q4 2017 and has held it in 15 quarters since.
  • 6 Meridian's Eli Lilly position peaked at $20.3M in Q4 2019.
  • 2,304 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2021.

Based on 6 Meridian's 13F filing for Q4 2021, filed 1 Feb 2022.